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PANDEMIC INFLUENZA A/H1N1 VACCINATION COVERAGE, ADVERSE REACTIONS, AND REASONS 
FOR VACCINE REFUSAL AMONG MEDICAL STUDENTS IN BRAZIL 
Eduardo Pernambuco de SOUZA(1) & Marcelo de Souza TEIXEIRA(2)
SUMMARY
The aim of this cross-sectional study was to determine, among medical students at a public university in Rio de Janeiro, Brazil, 
the acceptance of the pandemic influenza A/H1N1 vaccine during the 2010 mass immunization campaign and the vaccine safety in 
this group and, among unvaccinated students, the reasons for refusing vaccination. Of a total of 858 students, 678 (79%) participated 
in the study. Vaccination coverage was 60.4% among students aged 20 to 39 years (an age group targeted for vaccination) and 43.8% 
among those who did not belong to this age group. The most frequent adverse reactions to the vaccine were pain at the injection site 
(8.7%) and fever (7.9%). There were no serious adverse reactions. Among students aged 20 to 39 years, the most common reasons for 
refusing the vaccine were “lack of time” (42.4%), “fear of adverse reactions” (41.9%), and “difficult access to the vaccine” (11.5%). 
Other reasons for vaccine refusal were “uncertainties about vaccine safety and efficacy” and “vaccination was not needed”. To increase 
the acceptance of the influenza vaccine, a comprehensive immunization program should be offered to these students.
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INTRODUCTION
Influenza virus infection among health-care personnel can result in 
staff illness, absenteeism, and nosocomial transmission of the virus to 
patients at increased risk for influenza-related complications7. Thus, annual 
vaccination against influenza is recommended for health-care workers and 
students in the health professions8,21. However, the vaccination coverage in 
both groups has been universally low, Brazil included5,11,16,20,25,29,33,35. Among 
health-care workers, misconceptions about the seasonal influenza vaccine 
and the disease have been identified in review studies as significant barriers 
to the acceptance of the vaccine13,14.
In April 2009, a new influenza A/H1N1 virus was identified in Mexico 
and, in a short time, spread to several countries. In June 2009, when more 
than 33,000 cases of the disease had been confirmed in 74 countries, the 
World Health Organization declared that the world was at the beginning 
of a new influenza pandemic37.
In Brazil, there were 44,544 confirmed cases of pandemic influenza 
A/H1N1, with 2,015 deaths in the second half of 2009. The incidence 
rates of the disease were higher in children under two years of age and in 
individuals aged 20 to 29 years. The highest mortality rates were observed 
in persons aged 50 to 59 years and 30 to 39 years and in children younger 
than two years. Approximately 75% of the deaths occurred in individuals 
with underlying chronic diseases24.
Pandemic influenza A/H1N1 vaccines were developed, and from 
September 2009 onward, immunization programs were implemented in 
several countries36. In Brazil, the Ministry of Health conducted a mass 
immunization campaign against pandemic influenza A/H1N1 from 
March to May 2010, and target groups for vaccination in this campaign 
were health-care workers, the indigenous population, pregnant women, 
children aged six to 23 months, individuals with chronic diseases, and 
adults aged 20 to 39 years22. Unlike in other countries9,28, in Brazil, 
medical students were not included in the health-care workers category 
in the definition of the target groups for vaccination against pandemic 
influenza A/H1N122. However, most of these students are young adults, 
an age group for which vaccination was also recommended.
At the time of the mass immunization campaign against influenza 
A/H1N1 in Brazil, a study had already reported a low acceptance 
of the influenza A/H1N1 vaccine among health-care workers10. The 
knowledge about attitudes and behavior of medical students concerning 
immunizations can contribute to a better planning of future vaccination 
campaigns in medical schools.
In this context, this study aimed to determine the acceptance of the 
pandemic influenza A/H1N1 vaccine during the 2010 mass immunization 
campaign implemented by the Ministry of Health and the vaccine safety 
among medical students at a public university in Brazil and the reasons 
for refusing vaccination among unvaccinated students. 
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MATERIALS AND METHODS
This cross-sectional study was conducted at the Universidade Federal 
do Estado do Rio de Janeiro Medical School. This medical school is one 
of the three public medical schools located in the city of Rio de Janeiro, 
Brazil, and offers a six-year course in medicine. Approximately one 
hundred forty students are admitted each year. Student training is held 
mainly at the university hospital, but also in other health-care facilities. 
All medical students enrolled at this school in the second semester of 
2010 were eligible to participate in the study. The invitation to participate 
was made during mandatory classes for students on different occasions.
A self-administered questionnaire, with open- and closed-ended 
questions was used to collect the following data: age, sex, and the 
students’ current year in medical school; vaccination status against 
pandemic influenza A/H1N1 after the mass vaccination campaign, which 
was conducted from March to May 2010; adverse reactions following 
vaccination, which the student considered as having a causal association 
with the vaccine and, among unvaccinated students, the reasons for 
refusing the vaccine. Most data were collected in November and 
December 2010, but some questionnaires were collected until April 2011.
The data were entered into an electronic database using double data 
entry, and a descriptive analysis was performed for all study variables. 
The 95% confidence interval was calculated for the pandemic influenza 
A/H1N1 vaccination coverage and for the frequency of adverse reactions. 
The odds ratio was used to estimate the association between gender and 
acceptance of the pandemic influenza A/H1N1 vaccine. Epi Info (version 
3.5.3 - 2011) was used for creating the study database and for analysis. 
The study was approved by the ethics review committee of the 
Gaffrée and Guinle University Hospital at the Universidade Federal do 
Estado do Rio de Janeiro, and all students signed an informed consent 
before entering the study.
RESULTS
In the second half of 2010, 858 students were enrolled at the 
Universidade Federal do Estado do Rio de Janeiro Medical School, and 
678 (79%) responded to the survey questionnaire. Response rate ranged 
from 63.0% among sixth-year students to 92.4% among fourth-year 
students (Table 1). The mean age of the students was 22.8 years ± 2.8 
(range: 17 to 49 years): 59.7% were female students, and 40.3% were 
male students. At the time of the vaccination campaign against pandemic 
influenza A/H1N1, 558 students (82.3%) were aged 20 to 39 years and, 
thus, belonged to an age group for which the vaccine was recommended. 
Information on age was missing for eight students.
Among students who were aged 20 to 39 years at the time of the 
immunization campaign, vaccination coverage was 60.4% (95% CI: 
56.2% to 64.5%), and among those who did not belong to this age group, 
vaccination coverage was 43.8% (95% CI: 34.4% to 53.4%). In the whole 
group, vaccination coverage was 57.5% (95% CI: 53.7% to 61.3%), and 
being female was positively associated with vaccination against pandemic 
influenza A/H1N1 (OR = 1.62; 95% CI: 1.17 to 2.24). Vaccination status 
was missing for five students (0.7%) (Table 2). Vaccination coverage 
ranged from 44.3% among third-year students to 67.1% among sixth-
year students (Table 1).
Among vaccinated students (n = 390), the frequency of adverse 
reactions was 17.9% (95% CI: 14.3% to 22.2%). The most common 
adverse reaction was pain at the injection site (8.7%), followed by fever 
(7.9%), prostration (3.8%), myalgia (3.6%), headache (2.3%), malaise 
(1.5%), nausea (1.0%), and local erythema and/or edema and/or heat 
(1.0%). Other adverse reactions reported by the students were cold/flu-
like symptoms (n = 4), pneumonia (n = 2), anorexia (n = 1), arthralgia (n = 
1), leg pain and syncope (n = 1), pharyngitis (n = 1), acute gastroenteritis 
(n = 1), and laryngitis (n = 1). Serious adverse reactions were not reported. 
Information concerning adverse reactions was missing for three students 
(0.8%). The frequency of adverse reactions was 19.0% among women 
and 15.9% among men (p = 0.44).
All unvaccinated students reported one or more reasons for refusing 
the vaccine. Among students aged 20 to 39 years, the most frequently 
reported reasons for not being vaccinated were “lack of time” (42.4%), 
“fear of adverse reactions” (41.9%), and “difficult access to the vaccine” 
(11.5%). Among students younger than 20 years or older than 39 years, 
the most frequent reasons were “not belonging to a target group for 
vaccination” (66.1%), “fear of adverse reactions” (24.2%), and “lack 
of time” (22.6%). Several other reasons for not being vaccinated were 
reported, including doubts about the vaccine safety and efficacy and the 
perception that vaccination was not needed (Table 3).
DISCUSSION
In the definition of the target groups for vaccination against pandemic 
influenza A/H1N1 in Brazil, students of the health professions were 
not included in the health-care personnel category22. However, in this 
study, most of the students (82.3%) were in an age group targeted for 
vaccination: individuals aged 20 to 39 years. Nevertheless, among 
these students, we found a moderately low adherence to the vaccination 
campaign, and approximately 40% of them were not vaccinated. On the 
other hand, among students younger than 20 years or older than 39 years, 
the vaccination coverage was higher than expected (43.8%) because the 
vaccine was not formally recommended for them. In total, only 57.5% of 
all students were vaccinated, and a low vaccination coverage was found 
even among students in the clinical years of medical school who have 
more frequent contact with patients. Therefore, almost half of all students 
might have been at risk of acquiring the infection and of transmitting 
the influenza A/H1N1 virus to vulnerable patients with whom they have 
contact during their training. 
Table 1
Response rate and pandemic influenza A/H1N1 vaccination coverage among 
medical students according to student´s year of medical school
Year of medical 
school
Response rate 
(%)
Vaccination coverage * 
(%)
First year 87.9 54.2
Second year 70.3 53.9
Third year 78.2 44.3
Fourth year 92.4 66.4
Fifth year 79.8 59.6
Sixth year 63.0 67.1
* p value: 0.002
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Table 2
Pandemic influenza A/H1N1 vaccination coverage among medical students according to gender and age
Students
Vaccination against pandemic influenza A/H1N1 
OR (CI) 1Yes No Unknown
n % n % n %
Age: 20 to 39 years
Male 128 54.0 107 45.1 2 0.8
Female 209 65.1 110 34.3 2 0.6
Total (n = 558) 337 60.4 217 38.9 4 0.7
Age: < 20 or > 39 years
Male 9 28.1 23 71.9 0 0.0
Female 40 50.0 39 48.8 1 1.3
Total (n = 112) 49 43.8 62 55.4 1 0.9
All students:2
Male 138 50.5 133 48.7 2 0.7 ref
Female 252 62.2 150 37.0 3 0.7 1.62 (1.17–2.24)
Total (n = 678) 390 57.5 283 41.7 5 0.7
1
 OR: odds ratio; CI: 95% confidence interval; 2 Age was missing for eight students.
Table 3
Reasons for refusing the pandemic influenza A/H1N1 vaccine among medical students by age group
Reason for refusing the vaccine
Age group
20-39 years (n = 217) 1 < 20 or > 39 years (n = 62) 1
n % n %
Lack of time 92 42.4 14 22.6
Fear of adverse reactions 91 41.9 15 24.2
Not belonging to a target group for vaccination 15 6.9 41 66.1
Difficult access to the vaccine 25 11.5 2 3.2
Uncertainty about vaccine efficacy, safety, "quality", benefits, or indications 12 5.5 - -
Vaccination was not needed 9 4.1 - -
Didn´t want 8 3.6 2 3.2
Out of town/missed the deadline 6 2.7 - -
Didn´t want to stand in line/vaccine was not available at the health-care unit 2 0.9 - -
Other reasons 2 8 3.6 3 4.8
1
 More than one answer was possible, and % does not sum up to 100%; 2 Other reasons were as follows: trusted in herd immunity; lack of consensus among the profes-
sors; false positive for HIV; financial interests; does not agree with the campaign; medical advice because of the use of methotrexate and entanercept; vaccine may 
interfere with my treatment for chronic anemia; lack of studies with the vaccine; allergy; the campaign was to other groups; and did not care because it is the same as 
seasonal influenza. 
According to a preliminary estimate of the Brazilian Ministry of 
Health in the 2010 mass immunization campaign, the pandemic influenza 
A/H1N1 vaccination coverage was more than 80% among target groups, 
including adults aged 20 and 29 years23. In our group, vaccination 
coverage was lower than this estimate. To our knowledge, there are no 
other studies reporting on the pandemic influenza A/H1N1 vaccination 
coverage among subsets of target groups in Brazil. However, a review 
study reported that the seasonal influenza vaccination coverage among 
the elderly, in some Brazilian cities, was also lower than the estimates 
of health authorities for the entire group17. Additional studies could 
contribute to a better understanding of the acceptance of influenza 
vaccination among different subsets of target groups in Brazil and to a 
better planning of future immunization campaigns.
In contrast, pandemic influenza A/H1N1 vaccination coverage in our 
group was higher than that reported by studies conducted in 2009/2010 
among university students in other countries19,31,32. In Athens, Greece, 
only 8% of 922 medical students had been vaccinated against pandemic 
influenza A/H1N1 by December 2009, and 67% of them reported that they 
would definitely or probably not accept the vaccine19. At a university in 
Texas, U.S. only 44% of 529 students interviewed were vaccinated against 
pandemic influenza A/H1N1 during a mass immunization campaign31. A 
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study conducted in India reported a vaccination coverage of only 12.7% 
among 802 university students32. In several countries, the pandemic 
influenza A/H1N1 vaccination coverage among health-care workers, 
including physicians, was also lower than the vaccination coverage 
observed among our students1-3,10,12,18,34,35. 
Different predictive factors for acceptance of the pandemic influenza 
A/H1N1 vaccine were identified among health-care workers, including 
gender, age, previous vaccination against seasonal influenza, and 
perceptions about the disease and the vaccine1-3,12,34. In our group, female 
students were more likely to have received the vaccine, but we did not 
evaluate other factors that could confound this association. In India, 
pandemic influenza A/H1N1 vaccination coverage was also higher among 
female university students32. In contrast, among health-care workers in 
Italy, women had a higher risk of not being vaccinated2. A study conducted 
with university students in the U.S. did not find an association between 
gender and acceptance of the vaccine31. 
Among students in the age group targeted for vaccination (20 to 
39 years old), the most common reasons for refusing the vaccine were 
“lack of time” (42.4%) and “fear of adverse reactions” (41.9%). Among 
students not belonging to this age group, “fear of adverse reactions” 
and “lack of time” were the second and third most frequent reasons, 
respectively. The lack of time could be justified by the student’s daily 
schedule and by the fact that vaccination was not available to them at the 
university. However, the vaccine was available at no cost in many health-
care facilities, and only about 15% of the students reported “difficult 
access to the vaccine” as a reason for not being vaccinated. Thus, the lack 
of time would probably not have been a significant barrier to vaccination 
if the students had considered this intervention an important strategy for 
preserving their health and the health of their contacts.
The influenza A/H1N1 immunization campaign was implemented in 
Brazil when millions of doses of vaccines had already been administered 
worldwide and the World Health Organization had reported that no 
safety concerns had been identified for any of the pandemic influenza 
vaccines36. Nevertheless, fear of adverse reactions was a significant 
barrier to the acceptance of the vaccine among our students. In studies 
conducted among university students19,32 and health-care workers in 
other countries1,3,10,34,35, fear of adverse reactions was also one of the most 
common reasons for non-acceptance of the influenza A/H1N1 vaccine, 
and other reasons identified in these studies for non-acceptance of the 
vaccine were, in general, similar to the reasons reported by our group.
Altogether, the reasons for refusing the vaccine reported by our 
students demonstrate that they had an inadequate knowledge about 
the efficacy, safety, indications, and contraindications of the influenza 
vaccine. Misconceptions about influenza and the vaccine had already been 
identified as significant barriers to the acceptance of the seasonal influenza 
vaccine among health-care workers13,14. Accordingly, the medical school 
should urgently provide educational activities regarding influenza and 
its prevention to these medical students.
Approximately 18% of our students reported adverse reactions to the 
vaccine, but there were no serious adverse reactions. In studies conducted 
among health-care workers2-4,12,26, the frequency of adverse reactions 
following vaccination against pandemic influenza A/H1N1 ranged from 
6.7% in Germany to 82.3% in Spain, and the adverse reactions reported by 
our group were, in general, similar to those described in these studies. The 
adverse reactions also were similar to those typically observed after the 
administration of seasonal inactivated influenza vaccines6. The frequency 
of adverse reactions reported by different studies cannot be compared 
because of several factors, including the use of different vaccines.
Our study has several limitations. Although the response rate was 
relatively high (79%), a selection bias may have occurred. Additionally, 
we did not investigate why students decided to be vaccinated, especially 
those students who did not belong to an age group targeted for 
vaccination, and we also did not investigate other predictive factors for 
acceptance of the pandemic influenza A/H1N1 vaccine besides gender. 
However, the main limitation is that the results of this study cannot 
be generalized to other medical students in Brazil, as the context in 
which vaccination occurred in other medical schools might have been 
different. On the other hand, to our knowledge, there are no other 
studies reporting on influenza A/H1N1 vaccination coverage among 
medical students in Brazil, and our results can contribute to a better 
understanding of attitudes and behavior of medical students concerning 
influenza immunization.
In conclusion, we identified a moderately low adherence to the 2010 
mass immunization campaign against pandemic influenza A/H1N1 
among medical students in Brazil. The main reasons for vaccine refusal 
were lack of time, fear of adverse reactions, and misconceptions about 
the vaccine. The vaccine was well tolerated. To prevent the nosocomial 
transmission of influenza to vulnerable patients, mandatory vaccination 
of health-care personnel has been proposed or has been implemented 
in some settings27,30. A recent study conducted in the U.S. reported 
that 77% of all medical schools offered influenza vaccines at no cost 
to students during the 2007/2008 season and suggested that annual 
influenza immunization of students could contribute to increase the 
acceptance of the vaccine among future health-care workers15. In Brazil, 
health authorities and medical schools should consider providing the 
influenza vaccine to medical students. However, a comprehensive 
immunization program is necessary to ensure a high vaccination 
coverage.
RESUMO
Cobertura vacinal para a influenza A/H1N1, reações adversas 
e motivos para a não aceitação da vacina entre estudantes de 
medicina no Brasil
O objetivo deste estudo transversal foi determinar, entre estudantes 
de medicina de uma universidade pública no Rio de Janeiro - Brasil, a 
aceitação da vacina contra a influenza A/H1N1 pandêmica durante a 
campanha de imunização em massa de 2010, a segurança da vacina neste 
grupo e, entre os estudantes não vacinados, os motivos para recusarem 
a vacinação. De um total de 858 estudantes, 678 (79%) participaram do 
estudo. Entre os estudantes de 20 a 39 anos de idade (um grupo etário 
alvo para vacinação) a cobertura vacinal foi de 60,4% e entre aqueles que 
não pertenciam a esta faixa etária a cobertura vacinal foi de 43,8%. As 
reações adversas à vacina mais freqüentes foram dor no local da injeção 
(8,7%) e febre (7,9%). Não ocorreram reações adversas graves. Entre os 
estudantes de 20 a 39 anos, os motivos mais freqüentes para recusarem 
a vacina foram “falta de tempo” (42,4%), “receio de reações adversas” 
(41,9%) e “difícil acesso a vacina” (11,5%). Outros motivos para a não 
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vacinação foram “incertezas sobre eficácia e segurança da vacina” e 
“vacinação não era necessária”. A fim de aumentar a aceitação da vacina 
contra a influenza, um programa de imunização abrangente deveria ser 
oferecido aos estudantes.
ACKNOWLEDGMENTS
We thank Mark Henry for reviewing our manuscript.
AUTHOR CONTRIBUTIONS
Both authors participated in all study phases. EPS coordinated the 
study.
COMPETING INTERESTS
The authors declare that they have no competing interests. 
REFERENCES
 
 1.  Alkuwari MG, Aziz NA, Nazzal ZA, Al-Nuaimi SA. Pandemic influenza A/H1N1 
vaccination uptake among health care workers in Qatar: motivators and barriers. 
Vaccine. 2011;29:2206-11.
 2.  Amodio E, Anastasi G, Marsala MG, Torregrossa MV, Romano N, Firenze A. 
Vaccination against the 2009 pandemic influenza A (H1N1) among healthcare workers 
in the major teaching hospital of Sicily (Italy). Vaccine. 2011;29:1408-12.
 3.  Barriere J, Vanjak D, Kriegel I, Otto J, Peyrade F, Esteve M, et al. Acceptance of 
the 2009 A(H1N1) influenza vaccine among hospital workers in two French cancer 
centers. Vaccine. 2010;28:7030-4.
 4.  Bias H, Quarcoo D, Meier-Wronski C, Wicker S, Seybold J, Nienhaus A, et al. Self-
reported adverse reactions in 4337 healthcare workers immunizations against novel 
H1N1 influenza. BMC Res Notes. 2011;4:297.
 5. Blank DL, Bodansky DM, Forbes A, Garde E, Story F, Roalfe AK, et al. Influenza 
vaccination of future healthcare workers: a cross-sectional study of uptake, knowledge 
and attitudes. Vaccine. 2010;28:4668-72.
 6.  Centers for Disease Control and Prevention. Influenza. In: Atkinson W, Wolfe S, 
Hamborsky J, editors. Epidemiology and prevention of vaccine-preventable diseases. 
12th ed. Washington DC: Public Health Foundation, 2011. Available from: http://www.
cdc.gov/vaccines/pubs/pinkbook/flu.html [cited: 2011, November15].
 7.  Centers for Disease Control and Prevention. Influenza vaccination of health-care 
personnel: recommendations of the Healthcare Infection Control Practices Advisory 
Committee (HICPAC) and the Advisory Committee on Immunization Practices 
(ACIP). MMWR Recomm Rep. 2006;55(RR-2):1-16.
 8.  Centers for Disease Control and Prevention. Prevention and control of influenza: 
recommendations of the Advisory Committee on Immunization Practices (ACIP), 
2008. MMWR Recomm Rep. 2008;57(RR-7):1-60.
 9.  Centers for Disease Control and Prevention. Use of influenza A (H1N1) 2009 
monovalent vaccine: recommendations of the Advisory Committee on Immunization 
Practices (ACIP), 2009. MMWR Recomm Rep. 2009;58(RR-10):1-8.
 10.  Centers for Disease Control and Prevention. Interim Results Influenza A (H1N1) 
2009 monovalent and seasonal influenza vaccination coverage among health-care 
personnel. United States, August 2009-January 2010. MMWR. 2010;59(12):357-62.
 11.  Dinelli MI, Moreira TN, Paulino ER, da Rocha MC, Graciani FB, de Moraes-Pinto 
MI. Immune status and risk perception of acquisition of vaccine preventable diseases 
among health care workers. Am J Infect Control. 2009;37:858-60.
 12.  Grau S, Luque S, Pi-Sunyer J, Horcajada JP, Villar R, Berenguer N, et al. Baja 
adhesión a un programa de vacunación contra la gripe A (H1N1) pandémica 2009 
entre el personal sanitario de una institución durante la fase de pandemia. Enferm 
Infecc Microbiol Clin. 2011;29:269-75.
 13.  Hofmann F, Ferracin C, Marsh G, Dumas R. Influenza vaccination of healthcare workers: 
a literature review of attitudes and beliefs. Infection. 2006;34:142-7.
 14.  Hollmeyer HG, Hayden F, Poland G, Buchholz U. Influenza vaccination of health 
care workers in hospitals - a review of studies on attitudes and predictors. Vaccine. 
2009;27:3935-44.
 15.  Lindley MC, Lorick SA, Spinner JR, Krull AR, Mootrey GT, Ahmed F, et al. Student 
vaccination requirements of U.S. health professional schools: a survey. Ann Intern 
Med. 2011;154:391-400.
 16.  Lopes MH, Sartori AM, Mascheretti M, Chaves TS, Andreoli RM, Basso M, et al. 
Intervention to increase influenza vaccination rates among healthcare workers in a 
tertiary teaching hospital in Brazil. Infect Control Hosp Epidemiol. 2008;29:285-6.
 17.  Luna EJ, Gattas VL. Effectiveness of the Brazilian influenza vaccination policy, a 
systematic review. Rev Inst Med Trop Sao Paulo. 2010;52:175-81.
 18.  Mak DB, Daly AM, Armstrong PK, Effler PV. Pandemic (H1N1) 2009 influenza 
vaccination coverage in Western Australia. Med J Aust. 2010;193:401-4.
 19.  Mavros MN, Mitsikostas PK, Kontopidis IG, Moris DN, Dimopoulos G, Falagas 
ME. H1N1v influenza vaccine in Greek medical students. Eur J Public Health. 
2011;21:329-32.
 20.  Mereckiene J, Cotter S, Nicoll A, Levy-Bruhl D, Ferro A, Tridente G, et al. National 
seasonal influenza vaccination survey in Europe, 2008. Euro Surveill. 2008;13(43).
pii:19017.
 21.  Ministério da Saúde. Brasil. Secretaria de Vigilância em Saúde. Manual dos Centros 
de Referência para imunobiológicos especiais. 3a ed. Brasília: Ministério da Saúde, 
2006. Available from: http://portal.saude.gov.br/portal/arquivos/pdf/livro_cries_3ed.
pdf [cited: 2011, November 19].
 22.  Ministério da Saúde. Brasil. Secretaria de Vigilância em Saúde. Estratégia 
nacional de vacinação contra o vírus influenza pandêmico (H1N1) 2009. Brasília: 
Ministério da Saúde, 2010. Available from: http://www.conass.org.br/arquivos/file/
informetecnico_05_3.pdf [cited: 2010, July 7].
 23.  Ministério da Saúde. Brasil. Secretaria de Vigilância em Saúde. Informe Técnico 
Quinzenal da Influenza. 2010;6:1-6. Available from: http://portal.saude.gov.br/portal/
arquivos/pdf/informe_influenza_6_julho_22_07_10_seg.pdf [cited: 2011, November 
15].
 24.  Ministério da Saúde. Brasil. Secretaria de Vigilância em Saúde. Influenza Pandêmica 
(H1N1) 2009 - Análise da situação epidemiológica e da resposta no ano de 2009. 
Bol Eletrônico Epidemiol. 2010;2:1-21. Available from: http://portal.saude.gov.
br/portal/arquivos/pdf/boletim_eletronico_influenza_25_03.pdf [cited: 2011, 
November 15].
 25.  Monto AS. Seasonal influenza and vaccination coverage. Vaccine. 2010;28(Suppl 
4):D33-44.
 26.  Park SW, Lee JH, Kim ES, Kwak YG, Moon CS, Yeom JS, et al. Adverse events 
associated with the 2009 H1N1 influenza vaccination and the vaccination coverage 
rate in health care workers. Am J Infect Control. 2011;39:69-71.
 27.  Poland GA. Mandating influenza vaccination for health care workers: putting patients 
and professional ethics over personal preference. Vaccine. 2010;28:5757-9.
 28.  Public Health Agency of Canada. Guidance Document on the Use of Pandemic 
Influenza A (H1N1) 2009 Inactivated Monovalent Vaccine. Revised november 
20, 2009. Available from: http://www.phac-aspc.gc.ca/alert-alerte/h1n1/vacc/pdf/
monovacc-guide-eng.pdf [cited: 2011, November 16].
SOUZA, E.P. & TEIXEIRA, M.S. - Pandemic influenza A/H1N1 vaccination coverage, adverse reactions and reasons for vaccine refusal among medical students in Brazil. Rev. Inst. Med. 
Trop. Sao Paulo, 54(2): 77-82, 2012.
82
 29.  Silveira MB, Perez DA, Yamaguti A, Saraiva EZ, Borges MG, de Moraes-Pinto MI. 
Immunization status of residents in pediatrics at the Federal University of Sao Paulo, 
Brazil. Rev Inst Med Trop Sao Paulo. 2011;53:73-6.
 30.  Stewart AM. Mandatory vaccination of health care workers. N Engl J Med. 
2009;361:2015-7.
 31.  Sunil TS, Zottarelli LK. Student utilization of a university 2009 H1N1 vaccination 
clinic. Vaccine. 2011;29:4687-9.
 32.  Suresh PS, Thejaswini V, Rajan T. Factors associated with 2009 pandemic influenza 
A (H1N1) vaccination acceptance among university students from India during the 
post-pandemic phase. BMC Infect Dis. 2011;11:205.
 33.  Takayanagi IJ, Cardoso MR, Costa SF, Araya ME, Machado CM. Attitudes of health 
care workers to influenza vaccination: why are they not vaccinated? Am J Infect 
Control. 2007;35:56-61.
 34.  Torun SD, Torun F. Vaccination against pandemic influenza A/H1N1 among healthcare 
workers and reasons for refusing vaccination in Istanbul in last pandemic alert phase. 
Vaccine. 2010;28:5703-10.
 35.  Virseda S, Restrepo MA, Arranz E, Magán-Tapia P, Fernandez-Ruiz M, de la Camara 
AG, et al. Seasonal and pandemic A (H1N1) 2009 influenza vaccination coverage 
and attitudes among health-care workers in a Spanish University Hospital. Vaccine. 
2010;28:4751-7.
 36.  World Health Organization. Statement from WHO Global Advisory Committee 
on Vaccine Safety about the safety profile of pandemic influenza A (H1N1) 2009 
vaccines. 18 December 2009. Available from: http://www.who.int/vaccine_safety/
GACVS_H1N1_Vaccine_Safety.pdf [cited: 2011, November 15].
 37.  World Health Organization. World now at the start of 2009 influenza pandemic. 11 
June 2009. Available from: http://www.who.int/mediacentre/news/statements/2009/
h1n1_pandemic_phase6_20090611/en/indexhtml [Cited: 2009, July 25].
 Received: 8 December 2011
 Accepted: 8 February 2012
